TUMOR CAVITATION IN PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER UNDERGOING CONCURRENT CHEMORADIOTHERAPY: INCIDENCE AND OUTCOMES

被引：0
|
作者：
Phernambucq, Erik C. [1 ]
Hartemink, Koen J. [2 ]
Smit, Egbert F. [1 ]
Paul, M. A. [2 ]
Postmus, Pieter E. [1 ]
Senan, Suresh [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
concurrent chemoradiotherapy; tumor cavitation; stage III NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [41] Benefit of Concurrent Versus Sequential Chemoradiotherapy in Elderly Patients With Stage III Non-Small Cell Lung Cancer
    Logtenberg, Marleen E.
    Tomlow, Ben
    Kastelijn, Elisabeth A.
    Schramel, Franz M. N. H.
    CLINICAL LUNG CANCER, 2022, 23 (02) : 116 - 121
  • [42] Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy
    Topkan, Erkan
    Selek, Ugur
    Ozdemir, Yurday
    Yildirim, Berna A.
    Guler, Ozan C.
    Ciner, Fuat
    Besen, Au A.
    Findikcioglu, Alper
    Ozyilkan, Ozgur
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (05): : 1123 - 1132
  • [43] Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer
    Ryan, Kellie J.
    Nero, Damion
    Feinberg, Bruce A.
    Lee, Choo Hyung
    Pimentel, Rodrigo
    Gajra, Ajeet
    Kish, Jonathan K.
    Seal, Brian
    FUTURE ONCOLOGY, 2020, 16 (01) : 4303 - 4313
  • [44] Palifermin Reduces Dysphagia in Patients with Locally-advanced Unresected Non-small-cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
    Schuette, W.
    Krzakowski, M.
    Massuti, B.
    Otterson, G.
    Lizambri, R.
    Wei, H.
    Berger, D.
    Chen, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S114 - S114
  • [45] Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy
    Huang, Taosheng
    Zhang, Huanqian
    Zhao, Yunzheng
    Li, Yanping
    Wang, Guofeng
    Zhang, Yunbo
    Guo, Dong
    Ji, Shengjun
    Sun, Zhenyou
    FUTURE ONCOLOGY, 2021, 17 (17) : 2141 - 2149
  • [46] Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer
    Samer Tabchi
    Normand Blais
    Marie-Pierre Campeau
    Mustapha Tehfe
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 381 - 387
  • [47] Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer
    Tabchi, Samer
    Blais, Normand
    Campeau, Marie-Pierre
    Tehfe, Mustapha
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (02) : 381 - 387
  • [48] Outcomes of Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer in South of Brazil
    Coelho, Juliano Ce
    Branco, Mariane Araujo
    Pirolli, Rafaela
    Muller, Carolina Beatriz
    Carissimi Schmidt, Luis Felipe
    Klamt, Fabio
    Geib, Guilherme
    Schwartsmann, Gilberto
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S684 - S684
  • [49] Surgery in stage III non-small-cell lung cancer
    Eberhardt, Wilfried E. E.
    Stamatis, Georgios
    Stuschke, Martin
    LANCET, 2009, 374 (9687): : 359 - 360
  • [50] Outcomes of concurrent chemoradiotherapy in small cell lung cancer
    Mccann, B.
    Harrow, S.
    LUNG CANCER, 2016, 91 : S59 - S59
12345